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INTRODUCTION 
Ruminants have a four-compartment stomach consisting of the rumen, 
the reticulum, omasum and abomasum or true stomach. The rumen is the 
largest of the four compartments and functions as a fermentation vat for 
70 - 80 percent of ingested digestible dry matter. This arrangement and 
highly specialized nature of the ruminant stomach has given rise to a 
digestive mechanism and energy metabolism different from those found in 
other mammals. 
In a reciprocally beneficial symbiotic relationship, the billions of 
microbes which live in the rumen ferment plant materials consumed by the 
host animal to form chiefly carbon dioxide, methane and volatile acids. 
The gases are excreted and the acids are absorbed and oxidized for energy. 
As a result of rumen fermentation only a very small amount of dietary 
glucose is available to the animal, hence ruminants have low blood glucose 
which remains low even after feeding. Thus, as a consequence of the unique 
digestive system, glucose and other nutritional factors which regulate 
insulin secretion in monogastrics seem to have a diminished role in 
ruminants. 
Since insulin is needed in ruminants as in nonruminants for the 
regulation of energy storage and growth, other factors must have assumed 
the role of regulating insulin secretion in ruminants. Knowledge of these 
factors is at present limited but necessary for a better understanding of 
the transformation of feed into meat and milk in ruminants. 
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Insulin is secreted by the beta cells of the pancreatic islets of 
Langerhan. In association with the beta cells are alpha cells which 
secrete glucagon. Until recently the function of glucagon has been 
obscure,; however, it is now attracting the interest of many scientists 
because of the possibility that it may have a local function which is to 
stimulate insulin secretion. It seems appropriate, therefore, to study 
the secretion of insulin and glucagon together. 
The inability to assay plasma levels of these hormones had in the 
past prevented the unequivocal assessment of secretion studies. Better 
interpretations are now possible because of improved techniques. 
Particularly important in this regard are the various immunoassay tech­
niques. It was the purpose of this study to develop a radioimmunoassay 
for glucagon and to investigate the effects of some nutritional factors 
on the secretion of insulin and glucagon in sheep. 
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LITERATURE REVIEW 
Control of Insulin and Glucagon Secretion 
Nutritional status 
By measuring changes in the number of alpha and beta cells (Hellman 
and Hellerstrom, 1959) or changes in liver glycogen and plasma free fatty 
acids (FFA)(Fuller and Diller, 1970) indirect evidence has been presented 
to show that during the fed state insulin secretion increases and falls 
during starvation in the rat; the converse being true for glucagon. More 
direct measurements of insulin and glucagon secretion in man and dog by 
radioimmunoassay methods have confirmed that insulin levels are high during 
the fed state and fall with starvation (Nestel, Carrol and Havenstein, 
1970; Unger et al., 1963; Vance, Buchanan and Williams, 1968; Anguilar-
Parada, Eisentraut and Unger, 1969). Glucagon results have been contro­
versial. Unger et al. (1963) and Anguilar-Parada, Eisentraut and Unger 
(1969) have reported a rise in glucagon during starvation in man. This 
was not confirmed by Vance, Buchanan, and Williams (1968) in either human 
subjects or dogs. On the contrary, they found glucagon to rise and fall 
together with insulin. 
Prolonged starvation apparently does not result in the establishment 
of a steady basal level of insulin. Freinkel, Mager and Vinnick (1968) 
have observed a diurnal variation in plasma insulin levels during starva­
tion. Insulin was found to be significantly higher in the mornings than 
in the evenings. They concluded there is a rhythmic cyclicity for 
insulin secretion which is intrinsically determined and can be sustained 
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without exogenous stimulation to insulinogenesis. 
Carbohydrates 
The elevation of blood glucose concentration above the fasting range 
(60 - 100 mg/100 ml) by oral or intravenous glucose administration to man 
or laboratory animals results in increased insulin secretion (Randle et al., 
1968; Karam et al., 1966; Ballotta and Kennedy, 1968). Ruminants have been 
shown to respond in a similar manner to intravenous injections of glucose 
(Boda, 1964; Horino et al., 1968). The stimulatory effect of glucose on 
insulin secretion has also been demonstrated Iji vitro. The rate of 
insulin secretion was found to vary with glucose concentration above 35 -
50 mg/100 ml (Grodsky et al., 1963; Coore and Randle, 1964). 
The effect of glucose on glucagon secretion appears to be dependent 
on the route of administration. Buchanan et al. (1967) and linger et al. 
(1968) have shown that glucose introduced intrajejunal or intraduodenal 
in dogs stimulates release of glucagon which is of intestinal rather than 
pancreatic origin. On the other hand, glucose infusion depresses and 
hypoglycemia stimulates pancreatic glucagon secretion (Foa et al., 1949; 
1952; Unger et al., 1962; 1968; Ohneda et al., 1968). The in vitro studies 
of Vance et al. (1968) have confirmed that glucagon secretion decreases as 
the concentration of glucose increases. 
The effects of other monosaccharides on the secretion of insulin and 
glucagon have also been investigated. Most of these studies have dealt 
more with insulin than glucagon. Mannose, fructose and glucosamine have 
been demonstrated to stimulate insulin secretion (Randle et al., 1968). 
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Fructose was effective only at very high concentrations (above 500 mg/100 
ml) while glucosamine was only slightly effective. Glucosamine may also 
inhibit glucose-induced insulin secretion (Randle et al., 1968; Karam 
et al., 1966; Martin and Bambers, 1965). It has also been reported that 
galactose, 2-deoxyglucose, N-acetylglucosamine, d-ribose, d-arabinose, 
mannoheptulose and phloridzin are either without effect on or inhibit 
insulin secretion (Randle et al., 1968; Karam et al., 1966; Vance et al., 
1968). The literature is, however, filled with conflicting observations 
on the effects of these sugars on insulin secretion. Pozza et al. (1958) 
found galactose stimulatory and fructose ineffective in dogs. Boda (1964) 
reported that both fructose and galactose stimulated insulin secretion in 
sheep. However, Grodsky et al. (1963) observed that galactose could not 
stimulate insulin secretion from isolated rat pancreas. These discrepan­
cies are probably due to differences in dosages, species or assay 
techniques. 
The effects of 2-deoxyglucose, glucosamine and fructose have been 
introduced as evidence to discount the direct involvement of the glucose 
molecule in the stimulation of insulin secretion (Frohman, 1969). 
Glucosamine and 2-deoxyglucose inhibit glucose-induced insulin secretion 
by inhibiting glucose metabolism. Glucosamine is thought to competitively 
inhibit glucose phosphorylation (Martin and Bambers, 1965). Frohman 
(1969) has stated that fructose stimulation of insulin secretion may 
simply result from its conversion to glucose since insulin secretion is 
not stimulated by fructose in patients with "essential fructose 
intolerance", where a deficiency of 1-phosphofructoaldolase exists. 
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This enzyme converts fructose-l-phosphate to dlhydroxyacetone phosphate 
and glyceraldehyde. However, fructose has been reported to stimulate 
insulin secretion in the absence of increased blood glucose in patients 
with glucose-6-phosphatase deficiency (Hug and Schubert, 1967). 
Consequently, it has been suggested that the trioses or subsequent inter­
mediates in the glycolytic pathway may actually be responsible for 
stimulating insulin secretion. Using sheep pancreas Montague and Taylor 
(1968) have shown that citric acid stimulates insulin secretion. However, 
Handle et al. (1968) failed to show any effect of pyruvate and citrate on 
insulin secretion in perfused rabbit pancreas. 
Although 2-deoxyglucose and mannoheptulose inhibit insulin secretion 
they have been observed to have no effect on glucagon secretion (Vance 
et al., 1968). Phloridzin has been found to induce glucagon secretion in 
dogs. This is probably due to its effect on hypoglycemia (Randle et al., 
1968). 
Fatty acids and ketones 
The effect of volatile fatty acids on insulin secretion has been 
investigated in ruminants for whom these acids form a major source of 
energy. Manns and Boda (1967) observed that propionate and butyrate 
stimulate insulin secretion and hyperglycemia in sheep. Acetate was 
without effect. By infusing propionate and butyrate into the pancreatic 
artery, Manns, Boda and Willes (1967) subsequently presented evidence to 
suggest that butyrate and perhaps propionate may exert their effects 
directly on the pancreas. In vitro studies of Montague and Taylor (1968) 
have also demonstrated that citrate, butyrate and octanoate may have a 
7 
direct effect on the sheep pancreas. However, they did observe that 
insulin release was positively correlated with the production of glucose-
6-phosphate in the medium. They explained their results as the effect of 
short chain fatty acids on the intracellular accumulation of citrate which 
may then affect phosphofructokinase, resulting in an inhibition of 
glycolysis and accumulation of glucose-6-phosphate. These results do not 
support the idea that the release of insulin brought about by sugars is 
mediated by glycolysis; for, in the presence of fatty acids, glycolysis 
is inhibited, but rather suggest that glucose has to be metabolized by 
some other pathway in order to stimulate insulin secretion. Presumably 
the pentose phosphate pathway is involved. 
Horino et al. (1968) have confirmed that propionate and butyrate 
stimulate insulin secretion in sheep as well as cattle while acetate is 
without effect. They also observed that propionate and butyrate have no 
effect in nonruminants. Apparently during the course of evolution species 
acquired insulin secretory response mechanism sensitive to the major 
nutrients or substrates utilized by that organism. 
Other short chain fatty acids — valerate, isovalerate, hexanoate, 
heptanoate and octanoate — have been found to stimulate insulin secretion 
in sheep (Horino et al., 1968). Increased insulin secretion has also been 
observed in humans in response to intravenous injections of medium chain 
triglycerides (composed mainly of C8 and CIO fatty acids) or long chain 
triglycerides (com oil) (Pi-Sunyer et al., 1969). In studies involving 
the measurement of both insulin and glucagon (Seyffert and Madison, 1967; 
Madison et al., 1968) triglyceride (cottonseed oil emulsion) infusion was 
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found to stimulate insulin and inhibit glucagon secretion in dogs. The 
mechanism of action of the long chain fatty acids is thought to be either 
a direct stimulatory feedback on the beta cells and an inhibitory feed­
back on the alpha cells or mediated through the action of ketone bodies. 
The ketone body hypothesis is based on the observations of Madison et al. 
(1964) in dogs and Sauls (1967) in man that ketone bodies stimulate 
insulin secretion. However, Horino et al. (1968) and Manns, Boda and 
Willes (1967) were unable to show any effect of beta hydroxybutyrate on 
insulin secretion in sheep. Evidence in support of the direct action 
theory has recently been presented in a study by Crespin et al. (1969). 
In this study, sodium oleate was infused directly into the superior 
pancreaticoduodenal artery of anesthetized dogs. They observed a 5 to 
20 fold increase in pancreatic venous insulin and a 3 to 6 fold increase 
in peripheral plasma insulin concentration within ten minutes. Linoleate 
was found to have the same effect. 
Amino acids 
By measuring plasma insulin changes in normal subjects following a 
protein meal or during the infusion of amino acids Floyd and his colleagues 
have demonstrated that insulin secretion occurs in response to amino acid 
load (Floyd et al, 1966a; 1966b; Fajans et al., 1967). Small changes in 
blood glucose concentrations could not account for the increase in 
insulin secretion. These same workers also showed that individual amino 
acids differ as to their ability to stimulate insulin secretion (Floyd 
et al., 1966b; Fajans et al., 1967). Of the amino acids studied the most 
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potent were arginine and lysine and the least potent was histidine. A 
mixture of the ten essential amino acids resulted in higher plasma 
insulin levels than arginine, the most potent amino acid. Other workers 
have confirmed some of these observations in man fPallotta and Kennedy, 
1968; Fineberg et al., 1970). Hertelendy, Machlin and Kipnis (1969) 
have also demonstrated that arginine infusion stimulates insulin secre­
tion in sheep. 
More recent work by Floyd and his colleagues in which several amino 
acid pairs were infused into human subjects indicates synergism between 
some amino acids. Synergism was observed between arginine and leucine, 
and arginine and phenylalanine; the synergism between arginine and 
leucine being greater than that between arginine and phenylalanine. 
However, there was no synergism between arginine and lysine or arginine 
and histidine or leucine and histidine (Floyd et al., 1970a). Amino 
acids and glucose have also been shown to have a synergistic effect on 
insulin secretion (Pallotta and Kennedy, 1968; Floyd et al., 1970b). 
The mechanism of action of amino acids on insulin secretion is not 
yet well understood. It appears that different amino acids may have 
different mechanisms, for example, chlorpropamide which accentuates the 
insulin releasing action of leucine and diazoxide which suppresses 
leucine-induced insulin secretion, were found to have no effect on the 
insulinogenic activity of arginine or a mixture of eight amino acids 
(Fajans et al., 1967). Frohman (1969) has suggested that the differences 
may be due to differences in metabolic pathway. 
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Infused or ingested amino acids and proteins have also been found to 
stimulate glucagon secretion (Pek et al., 1968; 1969). However, some 
differences in response were found. Leucine was found to have no effect 
on glucagon secretion (Pek et al., 1969) and arginine was found to be more 
potent in stimulating glucagon secretion than a mixture of the ten 
essential amino acids (Pek et al., 1968). 
Cations 
Using isolated perfused rat pancreas Grodsky and Bennett (1966) have 
shown that there is a specific requirement for calcium for the insulin 
secretion induced by glucose. Manganese was not essential nor could it 
substitute for calcium. They also observed that potassium directly 
stimulated insulin secretion in the absence of glucose when its concen­
tration was increased from 4 to 8 mEq per litter. Other workers have con­
firmed these observations (Milner and Hales, 1968; Hales and Milner, 
1968). Hales and Milner (1968) made the additional observation that 
extracellular sodium is a prerequisite for secretion and suggested that 
depolarization and/or influx of sodium across beta cell membrane leads 
to insulin secretion. 
Little or no information is available with respect to glucagon 
secretion. Since the primary effects of the cations are on the membrane, 
the same principles may also apply to glucagon. 
Intestinal factors 
Mclntyre et al. (1964; 1965) reported that the hyperglycemia induced 
by oral or intrajejunal glucose in man was more effective in stimulating 
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insulin secretion than a comparable hyperglycemia induced by intravenous 
glucose. They attributed their findings to an intestinal factor(s) which 
affected insulin secretion. Dupre and Beck (1966) supported this 
hypothesis by showing that extracts of porcine intestinal mucosa infused 
simultaneously with glucose greatly elevated insulin-like activity than 
when glucose alone was administered intravenously. Evidence has 
accumulated to implicate glucagon, secretin, gastrin, and pancreozymin. 
In 1948, Sutherland and deDuve demonstrated the existence of a "glucagon-
like" hyperglycemic factor in the intestine. More recent studies have 
established that the intestinal tract does indeed contain substances 
which are both immunologically and biochemically related to glucagon 
(Valverde et al., 1968; 1969). Orci et al. (1968) have presented 
structural evidence for glucagon producing cells in the intestinal mucosa 
of the rat. It has also been shown that there is release of glucagon 
after oral glucose but not after intravenous administration, and that the 
rise in glucagon is not of pancreatic origin (Unger et al., 1968; 
Buchanan et al., 1967). 
Since the demonstration by several workers that glucagon stimulates 
insulin secretion both in vivo (Samols, Marri and Marks, 1966; Ketterer, 
Eisentraut, and Unger, 1967; Sussman and Vaughan, 1967) and in vitro 
(Grodsky et al., 1967) it has been suggested that the role of intestinal 
glucagon is to stimulate insulin secretion and that pancreatic glucagon 
may also have a local function. 
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By using purified extracts, Unger et al. (1967), Dupre et al. (1969), 
and Kahll, Mcllhaney and Jordan (1970) have demonstrated that secretin, 
gastrin and pancreozymin stimulate the secretion of both insulin and 
glucagon. Because small changes in insulin secretion in normal subjects 
may remain undetected as the results of hepatic clearance and the dilution 
of hepatic vein plasma, Kaess, Schlierf and von Mikulicz-Radecki (1970) 
have shown by by-passing the liver that the secretion of insulin produced 
by the liberation of endogenous secretin occurs at physiological doses of 
HCl and may be proportional to the rate of influx of h"*" into the duodenum. 
Other hormones 
The inhibitory effect of epinephrine on insulin secretion has been 
demonstrated in man (Porte and Williams, 1966; Karam et al., 1966), monkey 
(Kris et al., 1966), dog (Altszuler et al., 1967; Kosaka et al., 1964), rat 
(Wright and Malaisse, 1968), pigs (Hertelendy et al., 1966), and sheep 
(Hertelendy, Machlin and Kipnis, 1969). It is believed that epinephrine 
exerts its effect by stimulating alpha adrenergic receptors of the beta 
cells (Porte, 1969). Epinephrine is probably responsible for the 
inhibitory effect of 2-deoxyglucose (Karam et al., 1966; Laszlo et al., 
1961; Wegienka, Grasso and Forsham, 1966). There is paucity of information 
about the effect of epinephrine on glucagon secretion. When given via the 
portal vein, epinephrine was found to be a poor stimulator of hepatic 
glycogenolysis as compared with systemic administration. This has been 
interpreted to mean that epinephrine stimulates glucagon secretion 
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(Edzinli and Sokal, 1966). 
It has been reported that corticotropin (ACTH) stimulates insulin 
secretion (Genuth and Lebovitz, 1965; Sussman and Vaughan, 1967). 
Cortisone was also found to elevate plasma insulin in hamsters (Campbell, 
Rastogi, and Hausler, 1966) and man (Klink and Estrich, 1964) and sheep 
(Bassett and Wallace, 1967). The mechanism of action of ACTH and 
cortisone appears to be different. Studies by Lebovitz and Pooler (1967a; 
1967b) suggest that ACTH like glucagon exerts its effect by activating the 
adenyl cyclase system of the beta cell. Cortisone on the other hand 
stimulates insulin secretion by virtue of its ability to induce hyper­
glycemia. There are reports that ACTH and cortisone may stimulate the 
activity of pancreatic alpha cells (Cavallero and Mosca, 1953; Foa and 
Galansino, 1962). The significance of these observations is dubious 
because of lack of specificity of the methods used for the determination 
of glucagon. 
Malaisse, Malaisse-Lagae and McCraw (1967) studied the effect of 
thyroxine on insulin secretion in rats. Thyroidectomy reduced insulin 
secretion. This was restored to normal by the administration of thyroxine 
(15 yg/kg). Treatment of normal rats with high doses of thyroxine (200 yg/ 
kg) resulted in decreased secretion of insulin. However, in vitro studies 
showed no effect of thyroxine on insulin secretion. Thyroxine is thought 
to exert its effect on insulin secretion by enhancing glucose absorption. 
It has been observed that insulin response to arginine is diminished 
in ateliotic dwarfs (Merimee, Burgess and Rabinowitz, 1967) but enhanced in 
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acromegalics (Fineberg et al., 1970). The latter authors concluded that 
the capacity of the pancreatic cells to release insulin is increased with 
prolonged exposure to excessive quantities of growth hormone (GK). These 
observations are in agreement with ^  vitro studies (Martin and 
Gagliardino, 1967) using pancreas from hypophysectomized and normal rats. 
However, GH probably does not have a direct effect on insulin secretion 
since ^  vitro incubation with the hormone does not result in enhanced 
insulin release (Bouman and Bosboom, 1965). Early reports that GH 
stimulated glucagon secretion (Abrams et al., 1953; Clarke et al., 1956) 
were later contradicted by the work of Sirek, Sirek and Best (1957). 
These workers found that the hyperglycemic factor released after treating 
dogs with growth hormone persisted after pancreatectomy. It was suggested 
that the hyperglycemic factor might be other substances like serotonin or 
catecholamines. It appears that although the anterior pituitary may have 
an indirect influence on the activity of the alpha cells and the secretion 
of glucagon, any evidence for a direct relationship between GH and glucagon 
secretion is, at best, circumstantial (Foa, 1964). 
Estrogens (or gonadal steroids) appear to stimulate insulin secretion. 
Spellacy, Carlson and Birk (1967) observed higher insulin levels during 
glucose load in a group of women on oral contraceptive tablets (Enovid). 
Similar observations have been made in sheep and cattle fed diethyl 
stilbestrol (DES) (Trenkle, 1969). The mechanism of action is not known 
but it is thought to be mediated via its effect on growth hormone. 
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Oxytocin, vasopressin and angiotension II have been reported to 
affect insulin secretion (Frohman, 1969). The significance of these 
observations is unknown since it is difficult to distinguish physiologic 
from pharmacologic effects. 
Neural regulation 
The discovery of nerve cells in rat embryonic pancreatic bud (Pictet 
et al., 1969) and observations from numerous studies involving the use of 
epinephrine (reviewed above under "other hormones") have suggested that 
the nervous system may play a role in pancreatic cytodifferentiation and 
secretion. Parasympathomimetic or cholinergic agents stimulate insulin 
secretion (Kaneto et al., 1968) while the inhibitory effect of epinephrine 
is abolished by alpha-adrenergic blocking agents. Beta cell adrenergic 
receptors have been divided into two classes — alpha and beta receptors. 
Alpha blockade stimulates and beta blockade inhibits insulin secretion. 
Conversely, stimulation of the alpha receptors inhibits and stimulation of 
the beta receptors stimulates insulin secretion (Porte, 1967; Gale et al., 
1970). The inhibition of insulin secretion by epinephrine is mediated 
through the activation of alpha adrenergic receptors. It has been 
reported by Turtle and Kipnis (1967) that the stimulation of beta 
adrenergic receptors may involve the stimulation of adenyl cyclase. 
Frohman et al. (1967) and Kaneto et al. (1967) have demonstrated that 
the parasympathetic system is involved in insulin secretion. Stimulation of 
the vagus was found to cause Immediate release of insulin. However, the 
findings of Nelson et al. (1967) are at variance with the above 
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observation. Nelson and his coworkers found no increased insulin secre­
tion due to vagal stimulation in dogs; instead they got a transient fall. 
They justified their results by arguing that since insulin hypoglycemia 
stimulates vagus function, it seemed inappropriate for vagal activity to 
augment insulin release further and thus perpetuate the hypoglycemic state. 
By radioautography of tritiated norepinephrine Esterhuizen et al. (1968) 
have shown that some of the nerves between the beta cells in the cat con­
tain norepinephrine granules. Cholinergic nerves surrounding the islet 
cells have also been identified (Daniel and Henderson, 1967). Stimulation 
of these nerves could result in very high local concentrations of 
norepinephrine or acetyl choline which would inhibit or stimulate insulin 
secretion as the case may be. 
The central nervous system pathways controlling insulin secretion have 
not been completely identified but the ventral hypothalamus appears to be 
involved. Rats with ventromedial hypothalamic lesions have been shown to 
have enlarged islets or elevated insulin levels (Hales and Kennedy, 1964; 
Frohman et al., 1969; Han et al., 1970). It appears that normally the 
ventromedial region of the hypothalamus exerts inhibitory influences on 
the islets, since lesions result in enlargement of the islets and elevation 
of plasma insulin. 
The effect of the nervous system on the secretion of glucagon has not 
received much attention. The rise in blood glucose observed after vagal 
stimulation strongly suggests that the vagus may influence glucagon 
secretion in the same manner as insulin secretion. This rise in glucose 
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is not blocked by phentolamine, an alpha adrenergic blocking agent 
(Frohman, Ezdinli and Javid, 1967). 
The nervous system appears to be important but not absolutely 
necessary for the secretion of pancreatic hormones. Animals with trans­
planted denervated pancreas are able to maintain normal blood glucose for 
weeks (Ota et al., 1968). 
Stress and exercise 
In a study in which men were subjected to physical stress and exercise 
Schalch (1967) found no changes in plasma insulin levels despite elevated 
plasma glucose and FFA. Using rats, Wright and Malaisse (1968) have 
demonstrated that the effect of exercise on insulin secretion is mediated 
via epinephrine. Exercise or epinephrine injection reduced insulin 
secretion; and after blockade of the rats sympathetic system, exercise 
induced a fall instead of a rise in blood sugar concentration, an 
abnormally small increase in FFA and no increase in body temperature. 
They concluded that endogenous epinephrine released during stress or 
exercise is sufficient to suppress insulin secretion even under conditions 
or hyperglycemia. 
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STUDIES ON THE RADIOIMMUNOASSAY OF GLUCAGON 
Principles 
The principles of the radioimmunoassay of protein and peptide hormones 
have been reviewed by Berson et al. (1964). Essentially it is based on 
the competition between labeled and unlabeled hormone for antibody. The 
125 binding of antibody to I -labeled hormone is reduced or inhibited in the 
presence of unlabeled hormone; the degree of inhibition being progressively 
greater as the amount of unlabeled hormone is increased. If known concen­
trations of hormone are used a standard curve can be obtained by plotting 
percentage of labeled hormone bound to antibody against concentration of 
unlabeled hormone. The concentration of endogenous hormones in plasma is 
determined by comparison with the curve relating percentage labeled hormone 
bound to concentration of hormone in known standard solutions. 
There are several variations of the radioimmunoassay of peptide 
hormones depending on the specific hormone or techniques for separating 
free hormone from hormone-antibody complex. There are, of course, other 
little details like reagents, temperature and duration of incubation 
which vary from one laboratory to the other. The studies to develop a 
radioimmunoassay for glucagon were patterned after a modification (Trenkle, 
1968) of Herbert's coated charcoal method for insulin (Herbert et al., 
1965). In the modified procedure, antibody to bovine insulin produced in 
guinea pigs is incubated in sodium barbital buffer pH 8.6 for five days at 
4°C with solutions of standard bovine insulin or the plasma samples being 
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assayed before addition of I -insulin. The tubes are incubated for 
additional two days at 4°C before addition of 1.5 ml of a suspension of 
coated charcoal (7.5g Norit A, 0.75g dextran-80 and 3g bovine serum 
albumin per 100 ml of the pH 7.4 acetate-barbital buffer defined by 
Herbert et al. (1965)). After an adsorption time of 1 - 2 hours the 
tubes are centrifuged at 4°C for twelve minutes at the speed of 2000 g. 
The supernatant containing insulin-antibody complex and degraded insulin 
is removed by aspiration and the radioactivity adsorbed to charcoal (or 
the labeled insulin no bound to antibody) counted in an automatic gamma 
counter. 
Investigations 
Materials and method 
Antibody production Three rabbits weighing 2.4 to 2.8 kg and four 
guinea pigs weighing 420 to 470g were immunized at monthly intervals for 
the first five months by subcutaneous injections of glucagon preparation as 
described by Unger et al. (1961). The rabbits received 1 mg glucagon per 
animal and the guinea pigs 0.5 mg per animal at each immunization. Because 
no detectable antibody was found in these animals during the first five 
months, the doses and schedule of injection were changed. The guinea pigs 
were placed on 1 mg per animal per injection and the immunization interval 
reduced to two weeks. The rabbits were continued on 1 mg per animal but 
at the new schedule. After five more injections, the animals with low 
antibody titer were abandoned. Those with reasonably high titer were 
immunized again for the last time and bled twice, ten and thirteen days 
later. Plasma from these animals was diluted 1:10 with barbital buffer 
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pH 8.6 containing 2.5 mg bovine serum albumin per ml and frozen. 
Glucagon (Calbiochem, Lot No. 72669) for injection was prepared by 
suspending the hormone in an emulsion of saline and complete Freund's 
adjuvant (1/1 V/V) to a final concentration of 1 mg per ml. Antibody 
production from each animal was studied by bleeding the animals ten days 
after each injection beginning from the third injection. The plasma or 
125 its dilution was incubated with a known amount of I -glucagon for two 
days at 4°C. At the end of this period free I^^^-glucagon was separated 
125 from antibody-bound I -glucagon by adsorption to the coated charcoal 
125 described previously. Reduction in free I -glucagon was regarded as an 
indication of antibody formation. 
The feasibility of constructing a standard curve was examined by the 
addition of different quantities of unlabeled glucagon to the reaction 
125 
mixtures and noting the corresponding decrease in the binding of I -
glucagon. 
Since commercial glucagon may contain insulin as an impurity the 
presence of antibody to insulin was also tested by incubating the antibody 
125 preparation with I -insulin. When antibody to insulin was detected in 
125 the preparation, the cross reaction between I -insulin and antibody to 
125 glucagon, and I -glucagon and antibody to insulin was studied. Two 
125 125 
approaches were followed: (1) known amounts of I -glucagon and I 
insulin were added separately and in combination to assay tubes containing 
different dilutions of the antibody preparation. The tubes were incubated 
for three days and the total activity bound to antibody was determined. 
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(2) Progressively increasing concentrations of unlabeled insulin were 
added to tubes containing constant amounts of the antibody preparation 
125 
and I -glucagon to study the ability of unlabeled insulin to inhibit 
125 the binding of I -glucagon. 
125 Glucagon or insulin was iodinated with I by the chloramine-T 
method of Greenwood and Hunter (1963) . The labeled hormones were purified on 
cellulose column as described by Berson and Yalow (1961). 
Assay conditions Optimum conditions for assaying glucagon using 
the modified coated charcoal method described for insulin was investigated. 
125 The rate of the binding reaction between antibody and I glucagon 
was studied by setting up several tubes containing constant amounts of 
antibody and I^ ^^ -glucagon and incubating at 4°C over varying lengths of 
time. The degree of binding at these periods was determined. The amount 
of antibody used was such that only about 50 percent of the radioactivity 
added could be maximally bound. The pH of both the barbital (or incuba­
tion) and the acetate-barbital (or charcoal) buffers was varied and the 
resultant effect on binding measured. 
The time required for the complete adsorption of all free glucagon 
to coated charcoal could be a critical factor in the assay. This was 
studied by adding coated charcoal suspension to tubes of four sets of 
standard curve assays. The four sets were limited to 5, 10, 15, or 20 
minutes adsorption time respectively. 
Glucagon is readily degraded by proteinases in plasma (Hazzard et al., 
1968; Unger et al., 1961). The effect of adding proteinase inhibitors to 
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standard curve and recovery assays containing plasma was studied by using 
trasylol and soybean trypsin inhibitor (SBTI). The ability of the assay 
to give repeatable plasma concentrations was also studied. Three lambs 
were bled and plasma from each animal divided into three portions and 
stored frozen. The portions were assayed on different days. The effect 
of plasma volume assayed on glucagon concentration (expressed in ng/ml) 
was also investigated. 
Results and discussion 
Antibody production After the fifth immunization, no detectable 
antibody titer was found in either the rabbits or the guinea pigs. 
However, when the dose of glucagon was increased and the interval between 
injections shortened to two weeks, detectable titers were observed; but 
it was not until after the tenth immunization that a reasonably high titer 
was found in one of the guinea pigs. Table 1 shows different dilutions of 
plasmas from guinea pig no. 31 and their binding capacity. For assays, 
0.1 ml of 1:200 dilution of the plasma was used. The 1:200 dilution was 
chosen because it was the highest dilution that could bind about 50 percent 
125 
of I -glucagon activity. The antibody production in this study was 
poor. This may have been due to four factors — method of preparation of 
antigen, method of administration, dose and time between immunizations. 
Studies by Assan et al. (1965) and Worobec et al. (1967) indicate that 
satisfactory antibody production is possible only when (1) glucagon is 
stabilized by conjugation to serum albumin or adsorbed on to 
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125 125 Table 1. Antibody dilutions and percentage of I -glucagon and I 
insulin activities bound 
125 125 
% I -glucagon % I -insulin 
Dilutions activity bound activity bound 
1:10 61.9 87.4 
1:100 56.2 84.8 
1:200 50.2 83.1 
1:500 31,3 78.8 
1:1000 13.7 68.9 
polyvinylpyrrolidone or beeswax (2) higher doses of glucagon are used 
(3) animals are immunized every two days or every week, and (4) glucagon 
is administered intramuscularly. 
Figure 1 shows a standard curve which demonstrates the specificity 
125 
of the binding between antibody and I -glucagon. As the quantity of 
unlabeled glucagon added to the reaction mixture increased, the binding 
125 
of I -glucagon decreased. Beyond 1.5 ng the curve flattens out. So 
for assaying plasma samples, standards of 0.1 to 1.5 ng were used. 
As suspected, the antibody preparation contained antibody to insulin 
(Table 1). In fact the insulin antibody titer was higher than that of 
glucagon. The main reason for this is that insulin is a more antigenic 
molecule. Table 2 and Figure 2, however, show that neither the presence of 
125 insulin antibody nor the addition of I -insulin interferes with the 
125 
specificity of the binding between antibody to glucagon and I -glucagon. 
125 125 
If I -glucagon and I -insulin were bound to the same antibody one 
would expect the total activity bound in column C to be less than the sum 
Figure 1. Glucagon standard curve (B equals the radioactivity bound 
to antibody when no unlabeled hormone was added and B is the 
activity bound to antibody in the standard or sample tubes) 
Figure 2. The ability unlabeled insulin and glucagon to compete with 
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of columns A and B (i.e., column D). But the results show that the 
total activity bound in column C equals the sum of A and B. This 
additivity in activity shows that the hormones are independently bound 
to different antibodies. The noninterference of insulin or its antibody 
in the glucagon binding reaction is further illustrated in Figure 2, 
which shows that unlabeled insulin does not inhibit the binding of I" 
glucagon to antibody to glucagon. 
.125 
125 Table 2. Specificity of I -glucagon for antibody to glucagon 
Treatments 
Total activity bound (cpm) 
B C 
T125 , I -glucagon 
125 125 125 







dilutions 1 10 649.0 1584.1 2212.7 2233.1 
1 100 606.9 1537.3 2163.2 2144.2 
1 200 609.4 1507.4 2117.9 2116.8 
1 500 516.6 1428.5 1922.1 1945.1 
1 1000 355.9 1250.0 1547.3 1605.9 
Assay conditions Figure 3 shows that the binding reaction between 
125 I -glucagon and antibody to glucagon is fast and about complete within 
six hours of incubation. About 83 percent of the maximum binding had 
taken place during this period. Thereafter, binding increased at a 
progressively slower rate. Since the completion of the reaction is not 
necessary for establishing a standard curve, it would seem that a twelve 
hour incubation time could be adequate. However, for routine assays, an 
125 
Figure 3. Rate of the binding reaction between I -glucagon and 
125 glucagon antibody (percent I -glucagon bound to 
antibody vs. time) 
Figure 4. The effect of charcoal adsorption time on the standard curve 
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incubation time of 48 hours was allowed. This practice was justified 
by the observation that such lengthy incubations did not result in any 
125 
appreciable degradation of I -glucagon. 
Varying the pH of either the incubation or charcoal buffer between 
8 - 8.6 and 7.4 - 8.6 respectively had no appreciable effect on the binding 
or adsorption reactions (Table 3). The combination of incubation buffer 
pH 8.6 and charcoal buffer pH 7.4 which produced the best binding was 
adopted. 
Table 3. Effect of pH on radioactivity bound to antibody 
Total activity bound (cpm) 
Incubation buffer pH 
Charcoal buffer pH 8.0 8.6 
7.4 787 857 
8.0 815 838 
8.6 818 821 
The adsorption of free glucagon to coated charcoal appeared to be 
instantaneous. There was practically no difference between five minutes 
and twenty minutes adsorption time. However, allowing the adsorption to 
take place for fifteen minutes or more resulted in a smooth standard curve 
(Figure 4). In other words, the points lie on or very close to the curve. 
Adsorption time of twenty minutes or more was used in routine assays. 
Figure 5. The effect of proteinase Inhibitors on the standard curve 
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Trasylol and SBTI had no significant (p>0.05) effect on the standard 
curve (Figure 5). Apparently there was no appreciable degradation of 
125 I -glucagon when incubated in buffer in the absence of plasma. However, 
when unlabeled glucagon was added to plasma, recovery was very poor, thus 
indicating some degradation. Recovery was improved by the addition of 
1000 ng SBTI (Table 4). Observations by Hazzard et al. (1968) suggest that 
endogenous glucagon is not susceptible to similar degradation except, 
perhaps, when samples have not been stored frozen or have been subjected to 




(ng) added to 0.2 ml 
plasma Control 1000 ng SBTI 
0.10 60 70 
0.25 64 72 
0.50 51 62 
0.75 46 52 
frequent freezing and thawing. In assaying plasma samples, the major 
problem is usually the degradation of labeled hormone since endogenous 
glucagon does not seem to undergo marked degradation. This problem, 
however, does not seem to be real when plasma samples assayed do not 
exceed 0.2 ml. In any case, unlike the double antibody method, the char-
125 
coal method offers a way of estimating I -glucagon degradation or 
"serum damage". This is done by adding control tubes containing plasma 
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and all other components of the reaction mixture, except glucagon antibody. 
It appears, therefore, that with the charcoal method, reasonably accurate 
data could be obtained without adding trasylol or any other proteinase 
inhibitor to plasma samples. Perhaps glucagon assays can best be 
improved by using high dilutions of high titer antibody and labeled 
glucagon of high specific activity. 
Figure 5 shows a comparison of the glucagon concentrations of the same 
plasma samples assayed on three different dates. The difference between 
concentrations of the same sample estimated on different dates was small. 
However, the relative differences between samples were maintained. These 
observations indicate that under similar conditions, the coated charcoal 
radioimmunoassay method can be expected to give consistent and repro­
ducible results. 
Table 5. Variability of glucagon measurements 
Glucagon concentration ng/ml 
Sample No. Day 1 Day 2 Day 3 Mean 
85 0.550 0.500 0.500 0.517 + 0.016 
99 1.000 1.075 0.925 1.000 + 0.043 
299 0.700 0.650 0.650 0.666 + 0.017 
579 0.450 0.450 0.475 0.458 + 0.014 
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Glucagon concentrations (ng/ml) obtained by assaying different 
volumes of the same plasma sample are shown in Table 6. The smallest 
volume, 0.1 ml, gave the highest concentration of 0.80 ng/ml which was 
about one and three-fifths times the concentration of glucagon as assayed 
from 0.2 ml and 0.4 ml of plasma. The 0.2 ml and 0.4 ml volumes gave 
reasonably similar results. The concentration of glucagon in 0.1 ml of 
plasma was found to be less than 0.1 ng which was the lowest standard used 
in the assay. Thus the concentration assigned to the 0.1 ml volume was 
determined from extrapolation and probably explains the exaggerated value. 
The use of 0.2 ml sample volume in routine assays was adopted. 
Table 6. The effect of plasma volume assayed on glucagon concentration 
(ng/ml) 








As a result of the preceding investigations a procedure for the 
routine assay of sheep plasma glucagon by the modified coated charcoal 
immunoassay was established. This is summarized in the flow diagram shown 
in Figure 6. 
Figure 6. A flow diagram for the modified coated charcoal glucagon 
Immunoassay 
32b 
0.20 ml glucagon standard or plasma 
+ 0.25 ml barbital buffer (containing bovine serum albumin, 
2.5 mg/ml) 
+ 0.1 ml antibody preparation 1:200 dilution (sufficient to 
bind approximately 50 percent of the labeled glucagon in 
the absence of competing unlabeled hormone) 
Mix 
4°C 48 hrs. 
125 
+ 0.05 ml I -glucagon (with approximate activity of 2000 
cpm) 
Mix 
4°C 24 hrs. 
+ 0.2 ml normal plasma added to tubes containing no plasma; 
and 0.2 ml barbital buffer added to plasma tubes. 
+ 1.0 ml coated charcoal suspension (7.5 g Norit A, 0.75 g 
dextran-80 and 3 g bovine serum albumin per 100 ml of the 















STUDIES ON THE EFFECTS OF SOME NUTRITIONAL FACTORS ON THE 
SECRETION OF INSULIN AND GLUCAGON IN SHEEP 
Experimental Procedure 
Experiment 1. The effect of increasing levels of glucose, propionate and 
butyrate on insulin secretion 
A 45.5 kg lamb with a catheter in the jugular vein was used for this 
study. The treatments and experimental design are shown in Table 7. 
Table 7. Experimental design for Experiment 1 
Periods Period I Period II Period III 
Treatments Glucose Propionate Butyrate 
0.3 mM/kg BW 0.5 mM/kg BW 0.25 mM/kg BW 
0.6 mM/kg BW 1.0 mM/kg BW 0.5 mM/kg BW 
1.0 mM/kg BW 2.0 mM/kg BW 1.0 mM/kg BW 
During each period, the order in which the different levels were adminis­
tered was randomly determined. After an overnight fast, the lamb was 
given an intravenous injection of the predetermined treatment and 
heparinized blood samples obtained at -30, 0, 10, 20, and 30 minutes after 
injection. The metabolites were made up in 40 ml volumes and injected 
over a five minute period. Glucose was dissolved in saline while pro­
pionate and butyrate were diluted in water and neutralized to pH 7.4. 
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During each period, an interval of one day was allowed between treatments. 
A two day interval was allowed between periods. 
During collection, the blood samples were chilled in ice or placed 
in a refrigerator at 4°C and later centrifuged at 4°C and 11000 g for twenty 
minutes and the plasma frozen until analyzed for insulin and glucose. All 
blood samples in other experiments were handled and processed in this way. 
Insulin was analyzed by the modified coated charcoal immunoassay method 
described previously. Glucose was analyzed by the Technicon Auto-
Analyzer method. 
The lamb was fed 0.91 kg per day of a 50 percent grain diet. The 
diet was composed of 35 percent cracked shelled corn; 10 percent ground 
corn cobs; 40 percent ground alfalfa hay; 6 percent soybean meal; 8 per­
cent molasses, and 1 percent trace mineralized salt. Except where other­
wise stated, all lambs used in other experiments were maintained on this 
diet. 
Experiment 2. The effect of different diets on rumen volatile fatty acids 
and plasma insulin levels 
The purpose of this experiment was to relate changes in rumen volatile 
fatty acids resulting from different diets to changes in plasma insulin 
levels. Six lambs (three pairs) with an average weight of 30 kg were used 
in a 3 X 3 Latin square design to study the effects of three diets on 
rumen volatile fatty acid patterns and plasma insulin levels. The lambs 
were kept in metabolism crates and fed 0.727 kg per day of 80 percent grain 
diet or 0.91 kg per day of 50 percent grain diet or 1.14 kg per day of hay. 
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The rations were approximately isonitrogenous and isocaloric. The 
animals were maintained on one diet for three weeks at the end of which 
they were fed a different diet. The first two weeks on each diet served 
as an adjustment period. During the third week, Jugular blood and rumen 
fluid samples were obtained on two alternate days, four hours after 
feeding. 
Rumen samples taken for volatile fatty acid analysis were obtained 
by means of a stomach tube (Raun and Burroughs, 1962) and prepared as 
described by Cottyn and Boucque (1968). The apparatus used was a dual 
column Aerograph, 1520 gas chromatograph with hydrogen flame ionization 
detectors and columns packed with twenty percent neopentyl-glycylsuccinate, 
two percent H^ PO^  on 60-80 mesh firebrick. The carrier gas was nitrogen. 
The temperatures were 195°C, 160°C and 205^ C at the injectors, column 
oven, and detectors, respectively. 
The blood samples were prepared and analyzed for glucose and insulin 
as previously described. 
The hay fed in this experiment was in the form of long, baled alfalfa 
hay. The 50 percent grain diet was of the same composition as that 
described in Experiment 1. The composition of the 80 percent grain diet 
was 20 percent ground alfalfa hay; 6 percent soybean meal; 65 percent 
rolled com; 8 percent molasses; and 1 percent trace mineralized salt. 
Experiment 3. The effect of feeding on rumen volatile fatty acid 
concentrations and plasma insulin and glucagon levels in sheep 
In Experiment 2, varying the level of grain in the diet was found to 
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have little or no effect on either proportions of rumen volatile fatty 
acids or plasma insulin levels. This was probably due to restricted feed 
intake and the fact that the animals on the hay diet tended to select the 
leaves and to reject the stems. The purpose of this experiment was to 
further study the possible role of rumen produced volatile fatty acids on 
insulin secretion by measuring volatile fatty acid production and plasma 
insulin levels after feeding. 
Four lambs with an average weight of 36 kg and previously trained to 
consume all their daily ration of 0.91 kg at one time were used in this 
study. The animals were fed and rumen fluid samples obtained at -2, -1, 
0, 1.5, 3, 5, 7, 12, and 24 hours post prandial. Two days later, jugular 
catheters were placed in each animal and blood samples obtained at the 
same time intervals after feeding. The rumen fluid and blood samples were 
prepared for analysis as previously described. The blood samples were 
analyzed for insulin, glucagon, free fatty acids and glucose. Plasma 
free fatty acid levels were determined by the method of Ko and Royer 
(1967). The other parameters were analyzed as previously described. 
Experiment 4. The effect of feeding on insulin secretion in milk-fed calves 
The main purpose of this experiment was to study the effect of feeding 
and starvation on insulin secretion in milk-fed, non-ruminating ruminants. 
Three-month-old calves with an average weight of 82 kg and maintained on 
milk from birth were used in this study. After an overnight fast the 
animals were each fed 450 g of Doughboy Calf Milk Replacer (Formula 308). 
This "formula" contained 20 percent crude protein and 20 percent fat. 
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Blood samples were obtained by means of catheters placed in the jugular 
veins at 0, 0.5, 1, 1.5, 2, 2.5, 3, 6, 12 and 24 hours after feeding. 
After 24 hours fasting, the animals were fed again and the last samples 
obtained one hour later. The blood samples were analyzed for insulin, 
glucose and FFÂ as previously described. 
Experiment 5. The effect of intravenous infusion of casein hydrolysate 
on insulin and glucagon secretion 
The primary purpose of this experiment was to study the effect of 
amino acids contained in casein hydrolysate on insulin secretion. A 
preliminary experiment was run in which the effect of a 5 percent solution 
(w/v) was studied. The casein hydrolysate (General Biochemicals, Chagrin 
Falls, Ohio, Lot No. 83027) was dissolved in IN NaOH and neutralized to 
pH 7.4 with HCl; distilled water was added to make up the volume. A 26.3 
kg lamb had catheters placed in both right and left jugular veins. One 
catheter was used for infusion and the other for withdrawing blood. The 
solution was infused for one hour after an overnight fast at the rate of 
3 mis per minute by means of a peristaltic infusion pump (Harvard 
Apparatus Co., Dover, Mass., Model 600-120). Blood samples were obtained 
at -30, 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes after the beginning 
of the infusion. The experiment was repeated five days later. 
Plasma insulin and glucose were measured as described previously. 
Plasma alpha amino nitrogen was measured by the method of Spackman, Stein and 
Moore (1958) modified for determination with the Technicon-Auto-Analyzer. 
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Hydrindantln was substituted for stannous chloride as the reducing agent 
in the ninhydrin reagent. 
After examining the data obtained from this preliminary study it was 
concluded that the amino acid concentration in the 5 percent casein 
hydrolysate solution was not high enough to stimulate insulin secretion. 
Another experiment involving four lambs with an average weight of 40 kg 
was conducted. A 10 percent casein hydrolysate solution was used in this 
experiment which was carried out essentially in the same manner as the 
preliminary study. Blood samples were obtained at -30, -15, 0, 15, 30, 
45, 60, 90 and 120 minutes after the beginning of the infusion of the 
test solution. The main difference was that saline was infused for 45 
minutes during the control period. This means that the first three 
samples taken at -30, -15 and 0 minutes were obtained during saline 
infusion. Plasma glucagon was measured in addition to the other factors 
measured in the preliminary experiment. 
Experiment 6. The effect of oleic acid on insulin and glucagon secretion 
Two lambs with an average weight of 35 kg were fasted overnight and 
Injected intravenously with 20 ml emulsion of 1.5 ml oleic acid in 30 ml 
of plasma; the pH was adjusted to 7.4. The plasma used had previously 
been obtained from the respective animals. Blood samples were obtained 
by means of jugular catheter at -30, -15, 0, 15, 30, 45, 60, 90 and 120 
minutes after injection. The samples were analyzed for free fatty acids, 
glucose, insulin and glucagon. 
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Experiment 7. The effect of butyrate on glucagon secretion 
Four lambs with an average weight of about 39 kg had catheters 
placed in their jugular veins. After an overnight fast they were injected 
intravenously with a 20 ml solution of butyric acid (1 mM per kilogram body 
weight) neutralized to pH 7.4 with sodium hydroxide. Heparinized blood 
samples were obtained at -30, -15, 0, 15, 30, 45, 60, 90, and 120 minutes 
after injection. The samples were analyzed for glucose, insulin and 
glucagon as previously described. The experiment was repeated using two 
lambs. This time blood samples were obtained at shorter intervals: -10, 
-5, 0, 5, 10, 15, 20, 25 and 30 minutes after injection. 
Experiment 8. The effect of glucagon on plasma metabolites and insulin 
secretion 
Glucagon (1 mg suspended in 10 ml of saline) was intravenously 
injected into two lambs weighing 33 and 43 kg, respectively. The lambs 
were fasted overnight prior to the inception of the experiment and blood 
samples were obtained by means of jugular catheters at -10, -5, 0, 5, 10, 
15, 20, 25, 30 and 40 minutes after injection. The samples were analyzed 
for glucagon, insulin, glucose, urea nitrogen, alpha amino nitrogen, and 
free fatty acids. Urea nitrogen was measured by the Technicon Auto-
Analyzer method. Other parameters were analyzed as previously described. 
Glucagon fractional turnover rate and half life were also estimated. 
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Results and Discussion 
Experiment 1. The effect of Increasing levels of glucose, propionate 
and butyrate on Insulin secretion 
The results are shown In Table 8. Plasma Insulin levels Increased 
as the concentrations of glucose, propionate and butyrate were Increased 
(p < 0.05). On a molar basis, butyrate was more Insullnogenlc than either 
glucose or propionate. Plasma glucose changes were also proportional to 
the concentrations of propionate and butyrate Injected (p < 0.05). Glucose 
Injection resulted In higher plasma glucose levels which did not vary to 
any great extent with the concentration of glucose injected. Glucose level 
per se does not appear to be the main factor regulating insulin secretion 
Induced by propionate and butyrate. Glucose Injection resulted in higher 
plasma glucose concentrations and less Insulin secretion in contrast to 
lower glucose concentrations and more insulin secretion from propionate 
and butyrate. This suggests that propionate and butyrate may also have a 
direct effect on the pancreas. The reason for the high potency of 
butyrate in provoking Insulin secretion is unknown. 
The mechanism of hyperglycemia from propionate and butyrate appears 
to be different. Propionate is converted to glucose through a pathway 
involving methyl malonyl CoA and subsequent conversion to succinate. 
The metabolism of butyrate on the other hand does not yield glucose 
(Armstrong, 1965). Phillips, Black and Holler (1965) observed that 
butyrate infusion activated liver phosphorylase and depleted liver 
glycogen. This suggests that the hyperglycemic effect of butyrate may 
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Table 8. The effect of different concentrations of glucose, propionate 
and butyrate on plasma insulin and glucose levels 
GLUCOSE 0.3 mM/kg BW* 0.6 mM/kg BW 1.0 mM/kg BW 
Plasma , 































B^W is the abbreviation for body weight. 
V^alues are the means for samples taken at 10, 20 and 30 minutes 
after injection of test solution. 
be brought about by glycogenolysis. 
Experiment 2. The effect of different diets on rumen volatile fatty 
acids and plasma insulin levels 
Increasing the level of grain in the diet had no significant effect 
on either the plasma insulin or plasma glucose levels (Table 9). The 
effect of the diets on acetate production was highly significant (p < 0.01). 
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The difference was due to the hay diet which resulted in a relatively 
high acetate concentration. The acetate values for the 50 percent and 
80 percent grain diets were similar but lower than for the hay diet. 
Propionate and butyrate production were not significantly affected by 
dietary treatment. Comparison of the means for the different treatments 
indicated that the mean propionate production from the hay diet was 
greater (p < 0.05) than the mean propionate production from the 50 percent 
grain diet but not different from the 80 percent grain diet. Butyrate 
concentration tended to be higher in the grain diets. 
On the whole, the hay diet resulted in more volatile fatty acid 
production than the grain diets. Similar observations were made by 
Luther (1964). The failure to show a direct relationship between level 
of grain and propionate production may have been due to two factors. 
Firstly, the hay diet was in the form of long hay and the lambs tended to 
select the leaves and tender parts, leaving the stems. Secondly, the 
diets were fed in restricted amounts. The lack of effect of the dietary 
treatments on propionate and butyrate was reflected on the insulin levels. 
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Table 9. The effect of different diets on rumen volatile fatty acids 
and plasma insulin levels 
Hay 50% grain 80% grain 
No. of lambs 6 6 6 
Plasma insulin ng/ml 0.53 0.49 0.38 
Plasma glucose mg/100 ml 70.6 72.27 70.7 
Rumen acetate mM/L 64.72 42.05 43.4 
Rumen propionate mM/L 17.15 10.28 14.73 
Rumen butyrate mM/L 4.9 5.7 7.7 
Experiment 3. The effect of feeding on rumen volatile fatty acid 
concentrations and plasma insulin and glucagon levels in sheep 
The mean rumen volatile fatty acid concentrations are shown in 
Figure 7. Following feeding, there was a rise in the concentration of 
acetate, propionate and butyrate (p < 0.01). Acetate concentrations 
reached the highest level three hours after feeding and then declined to 
a plateau between seven and twelve hours after feeding. By twenty-four 
hours post-prandial the levels had declined to about pre-feeding concen­
trations. The changes in propionate concentration paralleled those of 
acetate. The peak level also occurred three hours after feeding; however, 
there was no conspicuous plateauing between seven and twelve hours post­
prandial. The rise in butyrate concentration was more gradual and the 
highest level was reached twelve hours after feeding. The butyrate 
Figure 7. Effect of time after feeding on rumen volatile fatty acid 
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pattern is perhaps a reflection of rapid absorption and utilization by 
the rumen wall. 
The effects of feeding on plasma hormones and metabolites are 
shown in Figure 8. There was little change in the mean glucose levels 
following feeding. The mean plasma free fatty acid levels declined after 
feeding to reach their lowest concentrations between three and five hours 
and then to rise to a significantly high level (p < 0.05) at twenty-four 
hours after feeding. The mean insulin levels increased following feeding 
and then dropped as fasting progressed. The increase achieved significance 
(p < 0.05) only at 1.5 hours after feeding. Plasma glucagon levels showed 
no significant changes. 
Since volatile fatty acid absorption varies directly with concentra­
tion it perhaps can be assumed that blood acetate, propionate and butyrate 
levels paralleled rumen concentrations. Schambye (1951) observed that 
portal blood concentrations of volatile fatty acids varied according to 
rumen concentration. The elevated insulin levels can therefore be 
attributed to the volatile fatty acids and other nutrients. 
Experiment 4. The effect of feeding on insulin secretion in milk-fed 
calves 
Figure 9 shows the effect of feeding on plasma glucose, insulin and 
free fatty acids in milk-fed calves. Feeding markedly elevated plasma 
glucose and insulin levels (p < 0.01). By thirty minutes after feeding 
plasma glucose had risen from 54 mg/100 ml to 164 mg/100 ml. This rise 
continued until two hours after feeding. Thereafter, glucose levels 
Figure 8. Effect of time after feeding on plasma glucose, free fatty 
acids (FFA), insulin and glucagon concentrations in adult 
sheep 
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Figure 9. Effect of time after feeding on plasma glucose, Insulin and 
















declined and by six hours after feeding had reached pre-feeding levels. 
Refeeding after twenty-four hours fast resulted in an immediate increase 
in plasma glucose. Changes in plasma insulin levels paralleled the changes 
in glucose concentrations. The immediate effect of feeding on plasma free 
fatty acid level was to lower it. This, however, was short-lived and the 
plasma free fatty acid levels remained relatively high until after six 
hours past feeding when there was a decline. By twenty-four hours after 
feeding plasma free fatty acids had risen to their highest point. 
Refeeding resulted in the lowering of the plasma free fatty acids. The 
reason for the relatively high plasma free fatty acid levels between one 
and six hours after feeding is not clear. It may have been due to the 
high fat content (20 percent) of the milk replacer fed to the calves. 
Experiment 5. The effect of intravenous infusion of casein hydrolysate 
on insulin and glucagon secretion 
The result of the preliminary experiment in which 5 percent casein 
hydrolysate was used is shown in Table 10. The infusion of 5 percent 
casein hydrolysate had no appreciable effect on either plasma glucose or 
plasma insulin. The elevation in plasma alpha amino nitrogen was statis­
tically significant (p < 0.01). 
By increasing the concentration of the casein hydrolysate solution to 
10 percent, greater elevation in plasma alpha amino nitrogen was achieved 
(Figure 10). As the solution was infused the alpha amino nitrogen concen­
trations gradually increased (p < 0.01) until the termination of the 
infusion. The changes in glucose and insulin levels were significant 
(p < 0.05) and paralleled the changes in alpha amino nitrogen. However, 
Figure 10. Effect of infusing 10 percent casein hydrolysate solution 
on plasma alpha amino nitrogen (AAN), glucose, insulin 
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Table 10. The effect of 5 percent casein hydrolysate on plasma insulin, 
alpha amino nitrogen and glucose concentrations 
Time (min.) after AAN^ GLUCOSE INSULIN 
infusion^ mM/L mg/100 ml mg/ml 
-30 3.0 73.2 1.06 
0 3.5 84.1 1.94 
15 4.0 72.2 2.79 
30 4.1 74.8 1.87 
45 4.3 70.2 1.31 
60 4.6 81.4 2.50 
75 3.2 66.7 1.16 
90 2.3 62.4 1.11 
105 2.7 74.2 1.00 
120 2.8 68.2 0.99 
^Casein hydrolysate was infused between 0 and 60 minutes. 
AAN = alpha amino nitrogen. 
insulin levels continued to rise until thirty minutes after the infusion 
had been stopped. This increase in insulin level at a time when the 
alpha amino nitrogen concentration was falling suggests that the level of 
alpha amino nitrogen per se was not the main factor controlling insulin 
secretion. 
Glucagon secretion was not appreciably affected by the infusion of 
casein hydrolysate. This is not in agreement with the work of Pek et al. 
(1968; 1969) who found the infusion or ingestion of amino acids to 
stimulate glucagon secretion in nonruminants. 
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Experiment 6. The effect of oleic acid on insulin and glucagon secretion 
From Figure 11, it can be seen that the injection of 1 ml of oleic 
acid elevated plasma free fatty acid levels in the two lambs (p ^  0.01). 
Glucose levels were not significantly affected. Insulin concentrations 
were elevated three-fold (p < 0.01) fifteen minutes after injection and 
thereafter declined. Oleic acid appeared to have an inhibitory effect on 
glucagon secretion. In the two animals used in this study, glucagon levels 
tended to go down following injection; however, this trend was not statis­
tically significant. These observations are in agreement with those 
reported by others in nonruminants (Seyffert and Madison, 1967; Madison 
et al., 1968; Pi-Sunyer et al., 1969; Crespin et al., 1969). 
Experiment 7. The effect of butyrate on glucagon secretion 
The results are shown in Figure 12 and 13. Butyrate significantly 
elevated glucagon levels from 0.93 to 1.31 ng (p c 0.01) within the 
first fifteen minutes. By thirty minutes after injection the glucagon 
concentrations had fallen to basal levels. Although the elevation of 
plasma glucagon levels amounted to only about 50 percent, the highest 
level in all the animals was observed at fifteen minutes after injection. 
This time period coincided with the peak elevation in plasma insulin 
(p < O.Ol) and plasma glucose (p ^  0.01) levels. The insulin and glucose 
data confirmed previous work by Manns and Boda (1967) and Horino et al., 
(1968). 
Since blood samples were obtained at fifteen minute intervals it was 
not possible to establish the exact time relationships between the peak 
Figure 11. Effect of injecting plasma emulsion of oleic acid on 
plasma free fatty acid (FFA), glucose, insulin and 
glucagon concentrations 
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Figure 12. Effect of intravenous injection of butyrate (1 mM/kg) 
on plasma glucose, insulin and glucagon concentrations 
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Figure 13. Time relationships between peaks in glucose, insulin and 
glucagon concentrations induced by butyrate 
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concentrations of glucagon, insulin and glucose. The experiment was 
repeated using two lambs and blood samples obtained at five minute 
intervals. The individual results from two animals — sheep #299 and 
#579 — are shown in Figure 13. Again the effectiveness of butyrate in 
stimulating glucagon secretion was observed. Glucagon, insulin and 
glucose levels were significantly elevated (p < 0.01). Rather noteworthy 
is the observation that peaks in glucagon secretion occurred before peaks 
in insulin or glucose levels: suggesting that glucagon might mediate 
either or both insulin secretion and hyperglycemia. Because of the 
shorter time interval between samples, higher insulin and glucagon 
concentrations were recorded at peak secretion. Sheep #579 with the 
higher glucagon levels also had the higher plasma glucose levels. This 
may have resulted in the slower decline in insulin levels from the peak 
concentration. 
Experiment 8. The effect of glucagon on plasma metabolites and insulin 
secretion 
Changes of plasma insulin and plasma metabolites following the 
injection of glucagon are shown in Figure 14. Plasma insulin levels were 
elevated 4-20 fold (p ^  0.05) after glucagon injection. The two lambs 
showed two insulin peaks. The first and smaller peaks occurred between 
five and ten minutes after injection. Then the insulin levels dropped to 
rise to higher points, ten to fifteen minutes later. Thereafter the 
insulin levels were relatively high until the termination of the experiment 
Figure 14. Effect of intravenous injection of glucagon on plasma insulin, 
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at forty minutes after injection. This multiphasic nature of insulin 
secretion has been observed by other workers and is thought to represent 
the immediate effect of a stimulus on the release of stored insulin 
followed by its effect on synthesis and secretion or different storage 
compartments (Curry et al., 1968; Floyd et al., 1970a)-
The effect of glucagon on glucose levels was immediate — rising from 
90 and 98 mg/100 ml to 144 and 163 mg/100 ml within five minutes for sheep 
#579 and 299 respectively (p <• 0.01). Glucose levels continued to rise 
with time to plateau at twenty-five minutes after injection. At this 
time there was about 100 percent increase in plasma glucose level. After 
fifteen minutes post-injection, plasma alpha amino nitrogen declined 
(p < 0.01). Plasma urea nitrogen (not shown in Figure 14) was not 
affected by glucagon administration. 
As reviewed by Foa and Galansino (1962) glucagon has been reported to 
have varied and even opposing effects on nitrogen metabolism. The dis­
crepancies may be due to differences in experimental systems and conditions, 
and the secondary effects of glucagon on epinephrine (Lawrence, 1967) and 
insulin (Samols et al., 1966; Karam et al., 1966) secretions. In isolated 
perfused rat liver, glucagon was shown to be protein catabolic, resulting 
in increased urea production. This catabolic effect was abplished by 
insulin (Miller, 1960). 
Glucagon appeared to have a dual effect on plasma free fatty acids. 
At five minutes post injection there was an elevation of plasma free fatty 
acids. Thereafter, the plasma free fatty acid levels declined until the 
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end of the experiment. The initial elevation of plasma free fatty acids 
is consistent with the lipolytic effect of glucagon (Beshwer and Ashmore, 
1966). The subsequent decline is perhaps another manifestation of the 
overriding effect of insulin (Sokal, Aydin and Kraus, 1956). 
The disappearance of exogenous glucagon was used to determine its 
fractional turnover rate and half life. Table 11 shows the changes in 
plasma glucagon levels following the injection of 1 mg exogenous hormone. 
Table 11. Disappearance of glucagon in plasma 
Time (min.) 
post- -10 -5 0 5 10 15 20 25 30 40 
injection 
Glucagon concentration (ng/ml) 
Sheep #299 .50 .48 .47 59.85 29.75 18.81 7.75 4.66 2.60 2.54 
Sheep #579 .58 .60 .62 85.50 40.00 25.00 15.67 9.19 5.25 3.95 
These data were used to plot regression lines according to the method 
described for thyroxine in cattle (Post and Mixner, 1961). This method 
assumes the disappearance of glucagon to be exponential in nature and to 
~bx be represented by the regression equation; "Y = ae , which may be trans­
formed to linear logarithmic form In Y = Ina - bx; where Y = plasma 
glucagon concentration, x = time in minutes, a = Y-axis intercept (value 
of Y when x = 0), b = regression coefficient or glucagon fractional turn­
over rate per minute. Figure 15 shows the regression lines plotted on a 
semi-logarithmic scale. Half life was calculated by dividing the natural 
Figure 15. The disappearance of glucagon injected into sheep 
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log of 2 by the turnover rate. 
The half life of about seven minutes observed in this experiment 
is in agreement with values of five to ten minutes reported in man 
(Samols et al., 1966) and rat (Buchanan et al., 1968). 
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GENERAL DISCUSSION 
Observations by Manns and Boda (1967) and Horino et al. (1968) have 
indicated that the volatile fatty acids may be more important than glucose 
in regulating insulin secretion in ruminants. Because of the nutritional 
importance of the volatile fatty acids the relationship between dose and 
insulin response was investigated. The effects of other nutritional 
factors on insulin secretion were also studied. Since insulin is one of 
the hormones involved in the regulation of growth, it was thought that 
knowledge of the factors regulating its secretion might prove useful in 
livestock production. 
Increasing the dose of either propionate or butyrate resulted in a 
corresponding increase in insulin secretion. Diet is known to have a 
marked effect on the proportion of volatile fatty acids produced in the 
rumen. By Increasing the level of grain in a ration, Donefer et al. 
(1963) and Luther (1964) have observed a decrease in the molar proportion 
of acetic acid with a concurrent increase in the molar proportion of 
butyric acid. Assuming that volatile fatty acid absorption will reflect 
rumen concentration (Schambye, 1951) one can postulate that increasing 
the level of grain in a ration will lead to increased insulin secretion. 
Indeed, some observations in the literature strongly suggest that this 
may be so. Injection of insulin or feeding high concentrate ration appears 
to have the effect of depressing milk fat content and milk yield (Gowen 
and Tobey, 1931; Jorgensen, Schultz and Barr, 1965). In glucose tolerance 
tests. Hale and King (1958) found that glucose disappeared faster in 
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grain-fed than hay-fed lambs. Trenkle (1966) observed higher insulin 
levels in corn-alfalfa fed lambs than in alfalfa hay fed ones. However, 
the present study was not successful in demonstrating any stimulatory 
effect of feeding grain on insulin secretion. The results can perhaps be 
explained on the basis of two factors. Firstly, the hay diet was in the 
form of long hay and the lambs tended to select the leaves and did not eat 
the stems. Secondly, diets were fed in restricted amounts. No 
appreciable differences in volatile fatty acid patterns were observed. 
Feeding milk to young calves or hay-concentrate diet to mature 
lambs resulted in elevated plasma insulin levels. The young calves had 
never been fed solid food and therefore possessed nonfunctional rumens. 
The lambs on the other hand, had been on solid food for a long time and 
had developed functional rumens. It was interesting to note that the 
nature of insulin response was different in the two types of animals. 
Insulin release was greater in the milk-fed calves than in the lambs, 
and while the rise in insulin levels paralleled the rise in plasma 
glucose concentrations in the calves there was no relationship between 
plasma glucose levels and plasma insulin levels in the lambs. On the 
contrary, insulin secretion paralleled rumen volatile fatty acid 
concentrations in the lambs. This indicates that glucose may be 
important in regulating insulin secretion in the milk-fed but not in 
the adult ruminant. The high fat content of the milk replacer may also 
have contributed to the hyperinsulinemia in the calves. 
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In nonrumlnants, nutrients stimulate the secretion of intestinal 
hormones which have been shown to be insulinogenic (Unger et al., 1968; 
Buchanan et al.,1967; Unger et al., 1967; Dupre et al., 1969; Kahil et al., 
1970). The end resuit is the amplification of insulin response. This 
may in part explain the extremely high levels of insulin observed in the 
milk-fed calves. However, very little is known about the role of these 
intestinal factors in promoting insulin secretion in the calf or newborn 
lamb. Knowledge of the relative importance of these hormones in regulating 
insulin secretion in ruminants is desirable for a better understanding of 
the effect of feeding. A recent study in adult goats indicates that 
secretin and cholecystoklnin-pancreozymin may not be important in 
stimulating insulin secretion in ruminants (Baile, Click and Mayer, 1969). 
Increased frequency of feeding has been known to result in faster 
growth rates in young sheep and cattle (Gordon and Tribe, 1952; Hardison 
et al., 1957; Horton and Nelson, 1961; Mohrman et al., 1959; Rakes et al., 
1957). In some cases a greater total feed intake accompanied the more 
frequent feedings and this offers a partial explanation for the improved 
performance. However, the cause of improved performance when total daily 
feed intake was kept the same is not known. Satter and Baumgardt (1962) 
fed equal amounts of feed at three different frequencies to some calves 
and observed that the animals had significantly greater nitrogen retention 
when fed eight times than when fed four or two times. The most frequent 
feeding also resulted in high and less fluctuation in volatile fatty acid 
concentrations. Since insulin is an important anabolic agent (Gaebler, 
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Liu and Zuchlewski, 1956; Wool et al., 1968) and it has been shown in 
this study that plasma insulin concentrations rise following feeding, 
the increased nitrogen retention resulting from frequent feeding could 
be attributed in part to the effect of insulin. 
The importance of animo acids in regulating insulin secretion in 
ruminants is dubious. An increase in plasma insulin levels was obtained 
only after a high concentration of casein hydrolysate was infused. It 
was noted that insulin levels continued to rise after the infusion had been 
stopped and at a time when alpha amino nitrogen concentration was falling. 
This suggests that the level of alpha amino nitrogen per se may not be the 
main factor controlling insulin secretion in ruminants. It is possible 
that a metabolic product of amino acids, notably urea, may be involved 
here. 
Oleic acid was found to stimulate insulin secretion and to depress 
glucagon levels. Because of the role of insulin and glucagon on lipolysis 
Madison et al. (1968) have characterized the effect of long chain fatty 
acids on insulin and glucagon secretion as feedback stimulation and 
inhibition which serve to modulate alterations in carbohydrate metabolism. 
Luyckx and Lefebvre (1970) have presented evidence which indicates that 
plasma free fatty acids may be important in regulating pancreatic 
endocrine secretions. Depressing plasma free fatty acid level by nicotinic 
acid infusion stimulated glucagon secretion while triglyceride infusion 
had the opposite effect. 
The stimulatory effect of butyrate on glucagon secretion indicates 
that the effect of butyrate on liver phosphorylase and hyperglycemia 
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(Phillips, Black and Moller, 1965) is mediated by glucagon. Significant 
in this regard is the observation that the glucagon peak occurred before 
that of glucose. This effect of butyrate appears to be a direct one 
since ketone bodies, the metabolic products of butyrate, have been shown 
to have no effect on hyperglycemia in sheep (Phillips and Black, 1966; 
Manns, Boda and Willes, 1967; Horino et al., 1968). 
The accumulation of ketone bodies results in ketosis, a pathological 
condition. Menahan, Schultz and Hoekstra (1966) have shown that 
hypoglycemia aggravates the accumulation of ketone bodies in goats. It 
is therefore teleologically significant that butyrate although ketogenic 
is also hyperglycemic through its effect on glucagon. The latter effect 
may serve to reduce the severity of the ketotic condition. The administra­
tion of glucagon to hypoglycemic, hyperketonemic sheep has been reported 
to increase blood glucose and decrease blood ketone levels (Ho and Reber, 
1957; Burtis et al., 1968). 
In Experiment 1, it was found that insulin secretion resulting from 
butyrate was more than could be accounted for on the basis of hyper­
glycemia. Similar observations have been made by other workers (Manns and 
Boda, 1967; Horino et al., 1968). Glucagon has been shown to stimulate 
insulin secretion in nonruminants (Samols et al., 1966; Karam et al., 
1966). The present study showed that glucagon also stimulates insulin 
secretion in the sheep. However, the insulin response following glucagon 
injection was considerably less than that observed after butyrate injection 
and a little smaller than would be expected from the hyperglycemia 
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produced. This reduced response is probably due to the high dose of 
glucagon used. Plasma glucagon concentrations rose from a mean basal 
level of 0.54 ng/ml to a mean of 72.68 ng/ml five minutes after the 
injection of exogenous glucagon in contrast to 1.4 ng/ml after butyrate 
injection. It is possible that the plasma glucagon concentration 
following glucagon injection was high enough to stimulate epinephrine 
secretion (Lawrence, 1967; Lefebvre et al., 1968) which inhibited or 
modified the effect of glucagon on insulin secretion (Hertelendy et al., 
1969). This view is strengthened by the observation that insulin concen­
trations were higher at the latter part of the experiment when plasma 
glucagon concentration was declining. Modest elevations in plasma 
glucagon concentration as observed following butyrate injection may be 
rather potent in stimulating insulin secretion. It is possible therefore 
that the hyperinsulinemia observed with butyrate is the result of 
synergism between glucose and glucagon. This does not preclude a direct 
effect of butyrate on the beta cells. 
Secretion of insulin and glucagon varied depending on the stimulus. 
Feeding and casein hydrolysate infusion stimulated insulin secretion but 
had no effect on glucagon secretion. Oleic acid stimulated insulin 
secretion but tended to inhibit glucagon secretion. The secretion of 
both insulin and glucagon was stimulated by butyrate. It is tempting 
to conclude from these observations that although glucagon stimulates 
insulin secretion, other factors which induce insulin secretion may do 
so without affecting glucagon secretion. However, because of the short 
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half life of glucagon and the dilution of pancreatic venous blood, a 
biologically significant increment of glucagon secretion may occur 
without a measurable change in peripheral glucagon level (Ketterer, 
Eisentraut and Unger, 1967). Therefore a better picture appears possible 
only when glucagon concentrations in pancreatic venous blood are 
measured. 
From this study it is evident that nutritional factors are 
involved in the regulation of pancreatic endocrine secretions. 
Nutrients absorbed following feeding directly or indirectly stimulate 
insulin secretion which is necessary for the storage of excess nutrients 
in the form of glycogen, fat and protein. 
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SUMMARY 
Experiments were conducted to study the relationship between dose 
of glucose, propionate and butyrate and plasma insulin levels in sheep. 
The effects of various diets, feeding, casein hydrolysate and oleic acid 
on insulin and glucagon secretion were also investigated. Increasing the 
dose of glucose, propionate or butyrate given intravenously resulted in a 
corresponding increase in insulin secretion; however, butyrate was more 
potent in stimulating insulin secretion than either glucose or propionate. 
Intravenous injection of butyrate was also found to stimulate glucagon 
secretion. This observation was considered important in view of the 
hyperglycemic effect of butyrate in sheep. In lambs fed restricted 
amounts of 0%, 50% or 80% grain diets no differences in rumen volatile 
fatty acid patterns or plasma insulin were observed. Feeding and casein 
hydrolysate infusion stimulated insulin secretion but had no effect on 
glucagon secretion. Oleic acid also stimulated insulin secretion but 
tended to inhibit glucagon secretion. The results of these studies 
indicate that nutritional factors are important in regulating insulin and 
glucagon secretion in the sheep. 
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APPENDIX 
Analysis of Variance Tables and Duncan's 
Multiple Range Test of the Means 
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Table 12. The effect of different doses of glucose on insulin secretion 
Source of Variation d.f. M.S. F 
Time 4 2.33 2.09 
Dose 2 8.33 7.50 
Error 8 1.11 
Total 14 
Dose® L M H 
Mean^  1.42 1.66 3.77 
o^se: L = low (0.3 mM/kg); M = medium (0.6 mM/kg); H = high 
(1.0 mM/kg). 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 13. The effect of different doses of glucose on plasma glucose 
levels 
Source of Variation d.f. M.S. F 
Time 4 1528.08 9.67 
Dose 2 190.94 1.2 
Error 8 157.88 
Total 14 
Dose® L M H 
Mean*) 112.82 123.20 123.82 
o^se; L = low (0.3 mM/kg); M = medium (0.6 mM/kg) ; H • high 
(1.0 mM/kg). 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 14. The effect of different doses of propionic acid on insulin 
secretion 
Source of Variation d.f. M.S. F 
Time 4 157.80 9.37 
Dose 2 75.66 4.49 
Error 8 16.82 
Total 14 
Dose* L M H 
Neanb 3.05 6.91 10.83 
o^se; L = low (0.5 mM/kg) ; M = medium (1.0 mM/kg) ; H = high 
(2.0 mM/kg). 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 15. The effect of different doses of propionic acid on plasma 
glucose levels 
Source of Variation d.f. M.S. F 
Time 4 1070.90 6.62 
Dose 2 1202.35 7.43 
Error 8 161.68 
Total 14 
Dose^  L M H 
Mean^  79.94 91.10 110. 
CO m
 
D^osef L = low (0.5 mM/kg); M = medium (1.0 mM/kg); H = high 
(2.0 mM/kg). 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 16. The effect of different doses of butyric acid on insulin 
secretion 
Source of Variation d.f. M.S. F 
Time 4 356.78 4.94 
Dose 2 320.87 4.45 
Error 8 72.08 
Total 14 
Dose^  L M H 
Mean^  4.89 6.58 19.53 
o^se: L = low (0.25 nM/kg) ; M = medium (0.5 mM/kg) ; H = high 
(1.0 mM/kg). 
Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 17. The effect of different doses of butyric acid on plasma glucose 
levels 
Source of Variation d.f. M.S. F 
Time 4 1508.92 4.15 
Dose 2 1994.85 5.48 
Error 8 363.43 
Total 14 
Dose^  L M H 
Meanb 80.34 95.6 119.94 
o^se; L = low (0.25 mM/kg); M = medium (0.5 mM/kg); H = high 
(1.0 mM/kg). 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 18. The effect of different diets on plasma insulin levels 
Source of Variation d.f. M.S. 
Animals 5 .0777 2.15 
Periods 2 .0043 0.119 
Treatments 2 .0354 0.98 
Error 8 .0361 
Total 17 
Treatments® CAB 
Meanf .38 .49 .53 
treatments; A = hay; B = 50% grain; and C = 80% grain. 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 19. The effect of different diets on plasma glucose levels 
Source of Variation d.f. M.S. 
Animals 5 65.36 1.67 
Periods 2 26.72 0.68 
Treatments 2 5.24 0.13 
Error 8 38.99 
Total 17 
Treatments* ACS 
Mean^  70.6 70.7 72.6 
T^reatments: A = hay; B = 50% grain; and C = 80% grain. 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 20. The effect of different diets on total rumen VFA concentration 
Source of Variation d.f. M.S. F 
Animals 5 126.50 0.76 
Periods 2 132.54 0.80 
Treatments 2 1326.65 8.02 
Error 8 165.22 
Total 17 
Treatments® B C A 
Meant 57.98 65.83 86.75 
T^reatments: A = hay; B = 50% grain; and C <= 80% grain. 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 21. The effect of different diets on the concentration of acetic 
acid in the rumen 
Source of Variation d.f. M.S. F 
Animals 5 44.97 .55 
Periods 2 70.33 .86 
Treatments 2 970.00 11.97 
Error 8 80.99 
Total 17 
Treatments® B C A 
Mean^  42.05 43.4 64.72 
T^reatments: A = hay; B = 50% grain; and C = 80% grain. 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 22. The effect of different diets on the concentration of 
propionic acid in the rumen 
Source of Variation d.f. M.S. F 
Animals 5 16.281 0.937 
Periods 2 2.734 0.157 
Treatments 2 72.794 4.1b9 
Error 8 17.375 
Total 17 
Treatments^  B C A 
Meant 10.28 14.73 17.15 
T^reatments: A = hay; B = 50% grain; and C = 80% grain. 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 23. The effect of different diets on the concentration of butyric 
acid in the rumen 


























T^reatments: A = hay; B = 50% grain; and C = 80% grain. 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 24. The effect of feeding and 24 hrs. fasting on plasma glucose 
levels in lambs 


























Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 25. The effect of feeding and 24 hrs. fasting on insulin secretion 
in lambs 
















0 7 12 5 3 1.5 
0.95 1.65 1.72 1.90 2.59 2.75 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 26. The effect of feeding and 24 hrs. fasting on plasma FFA levels 
in lambs 






























Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 27. The effect of feeding and 24 hrs. fasting on glucagon secretion 
in lambs 






























^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 28. The effect of feeding and 24 hrs. fasting on total rumen VFA 
concentrations in lambs 
Source of Variation d.f. M.S. F 
Animals 3 263.137 2.219 
Time 8 1603.802 13.530 
Error 20 118.533 
Total 31 
Time (hrs.) 0 24 7 12 1.5 5 3 
Mean* 38.30 49.43 70.71 70.83 75.96 79.24 88.59 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 29. The effect of feeding and 24 hrs. fasting on the rumen acetic 
acid concentrations in lambs 
Source of Variation d.f. M.S. F 
Animals 23. 127.193 2.48 
Time 8 730.728 14.25 
Error 20 51.280 
Total 31 
Time (hrs.) 24 0 12 7 1.5 5 3 
Mean* 35.99 36.61 49.51 49.59 54.12 55.69 62.87 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 30. The effect of feeding and 24 hrs. fasting on the rumen 
propionic acid concentrations In lambs 




















7 5 1.5 3 
12.91 15.30 15.95 18.05 
Any two means not underscored by the sasie line are significantly 
different at 0.05 level of probability. 
Table 31. The effect of feeding and 24 hrs. fasting on the rumen butyric 
acid concentrations in lambs 
















0 24 1.5 3 7 5 12 
4.21 5.80 5.88 7.66 8.20 8.24 8.91 
*Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 32. The effect of feeding and 24 hrs. fasting on plasma FFÂ levels 
in milk-fed calves 














Time (hrs.) 12 1.5 25 2.5 1 1.5 3 
Mean® 
24 
556 608 730 754 768 772 773 871 910 910 1273 
Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 33. The effect of feeding and 24 hrs. fasting on insulin secretion 
in milk-fed calves 














Time (hrs.) 24 12 0 6 .5 1 25 1.5 2 3 2.5 
Mean* 0.15 0.39 0.32 1.2 2.49 3.57 4.26.6.02 9.15 12.83 13.39 
Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 34. The effect of feeding and 24 hrs. fasting on plasma glucose 
levels in milk-fed calves 














Time (hrs.)O 6 24 12 25 .5 13 1.5 2.5 2 
Mean* 53.9 56.8 60.6 74.6 163.4 163.7 187.6 189.7 192.9 195.0 200.6 
Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 35. The effect of the infusion of 5 percent casein hydrolysate 
solution on plasma glucose levels in sheep 




















62.4 66.7 68.2 70.2 72.2 74.2 74.8 78.6 81.4 
Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 36. The effect of the Infusion of 5 percent casein hydrolysate 
solution on plasma alpha amino nitrogen concentration in sheep 
Source of Variation d.f. M.S. F 
Period 1 12.01 148.089 
Sample time 9 0.99 12.207 
E-ror 9 0.0811 
Total 19 
Time (min.) 
Mean^  2.3 2.7 2.8 3.2 3.2 4.0 4.1 4.3 4.6 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 37. The effect of the infusion of 5 percent casein hydrolysate 
solution on Insulin secretion in sheep 
Source of Variation d.f. M.S. F 
Period 1 1.44 1.22 
Sample time 9 .87 0.737 
Error 9 1.18 
Total 19 
Time (min.) 120 105 90 75 45 0 30 60 15 
Mean* 0.99 1.00 1.11 1.16 1.31 1.5 1.87 2.50 2.79 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 38. The effect of the infusion of 10 percent casein hydrolysate 
solution on plasma alpha amino nitrogen concentrations in 
sheep 
Source of Variation d.f. M.S. 
Animals 3 22.183 126.039 
Time 8 12.712 72.227 
Error 24 0.176 
Total 35 
Time (min.) 0 120 90 15 30 45 60 
mean* 2.04 2.86 3.67 4.20 5.18 6.12 6.56 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 39. The effect of the infusion of 10 percent casein hydrolysate 
solution on plasma glucose levels in sheep 
Source of Variation d.f. M.S. 
Animals 3 3682.04 41.95 
Time 8 228.81 2.60 
Error 24 87.76 
Total 35 
Time (min.) 120 0 15 90 30 45 60 
Mean* 64.7 69.7 77.9 79.7 79.8 82.6 84.3 
*Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 40. The effect of the Infusion of 10 percent casein hydrolysate 
solution on insulin secretion in sheep 
Source of Variation d.f. M.S. 
Animals 3 29.141 2.519 
Time 8 27.478 2.375 
Error 24 11.568 
Total 35 
Time (min.) 0 15 30 45 120 60 90 
mean* 0.59 0.82 1.13 1.94 2.78 4.19 8.52 
i^jiy two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 41. The effect of the infusion of 10 percent casein hydrolysate 
solution on glucagon secretion in sheep 
Source of Variation d.f. M.S. F 
Animals 3 0.04267 3.727 
Time 8 0.00514 0.449 
Error 24 0.01145 
Total 35 
Time (min.) 15 45 30 0 90 120 60 
Mean* 0.64 0.68 0. 68 0.68 0.69 0.74 0.75 
*Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 42. The effect of plasma emulsion of oleic acid on plasma FFA 
Source of Variation d.f. M.S. F 
Animals 1 42437.56 28.83 
Time 8 11333.62 7.70 
Error 7 1471.92 
Total 16 
Time (min.) 0 60 90 120 15 30 45 
Mean* 288 338 366 403 410 459 468 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 43. The effect of plasma emulsion of oleic acid on plasma glucose 
levels in sheep 
Source of Variation d.f. M.S. F 
Animals 1 3068.578 15.082 
Time 8 113.502 0.557 
Error 7 203.451 
Total 16 
Time (min.) 120 45 0 15 60 90 30 
Mean* 77.9 81.6 83.0 86.6 87.0 96.4 98.2 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 44. The effect of plasma emulsion of oleic acid on glucagon 
secretion in sheep 
Source of Variation d.f. M.S. 
Animals 1 0.060 7.50 
Time 8 0.011 1.38 
Error 7 0.008 
Total 16 
Time (min.) 45 120 15 30 60 0 90 
Mean* 0.59 0.60 0.63 0.65 0.71 0.73 0.79 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 45. The effect of plasma emulsion of oleic acid on insulin 
secretion in sheep 
Source of Variation d.f. M.S. 
Animals 1 0.024 12 
Time 8 0.236 118.0 
Error 7 0.002 
Total 16 
Time (min.) 0 90 120 60 45 30 15 
Mean* 0.56 0.57 0.66 0.84 0.94 1.17 1.54 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 46. The effect of butyrate on plasma glucose levels in sheep 
(Experiment 7a) 
Source of Variation d.f. M.S. 
Animals 3 636.11 4.14 
Time 8 3254.54 21.22 
Error 24 153.32 
Total 35 
Time (min.) 90 120 0 60 45 30 15 
Mean* 80.4 91.5 95.2 99.6 114.9 141.1 169.4 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 47. The effect of butyrate on insulin secretion in sheep 
(Experiment 7a) 
Source of Variation d.f. M.S. F 
Animals 3 11.05 2.93 
Time 8 71.64 19.05 
Error 24 3.76 
Total 35 
Time (min.) 120 90 0 60 45 30 15 
Mean* 0.22 0.30 0.35 0.80 1.62 4.80 13.00 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 48. The effect of butyrate on glucagon secretion in sheep 
(Experiment 7a) 
Source of Variation d.f. M.S. F 
Animal 3 0.69 72.63 
Time 8 0.0725 7.63 
Error 24 0.0095 
Total 35 
Time (min.) 60 30 45 90 0 120 15 
Mean* 0.88 0.89 0.89 0.89 0.93 0.96 1.31 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 49. The effect of butyrate on plasma glucose levels in sheep 
(Experiment 7b) 
Source of Variation d.f. M.S. 
Animal 1 789.37 12.43 
Time 8 1476.50 23.25 
Error 8 63.48 
Total 17 
Time (min.) 0 30 5 25 20 15 10 
Mean* 100.7 114.2 130.0 137.2 146.7 164.5 169.0 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 50. The effect of butyrate on glucagon secretion in sheep 
(Experiment 7b) 
Source of Variation d.f. M.S. 
Animals 1 0.6651 214.55 
Time 8 0.0913 29.45 
Error 8 0.0031 
Total 17 
Time (min.) 30 25 0 20 15 10 5 
Mean® 0.58 0.68 0.69 0.76 0.82 1.05 1.24 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 51. The effect of butyrate on insulin secretion in sheep 
(Experiment 7b) 
Source of Variation d.f. M.S. F 
Animals 1 3.1584 0.98 
Time 8 160.4775 49.81 
Error 8 3.2218 
Total 17 
Time (min.) 0 30 25 20 5 15 10 
Mean* 0.73 4.24 6.35 10.68 17.64 17.68 24.96 
®Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 52. The effect of glucagon on insulin secretion in sheep 
Source of Variation d.f. M.S. 
Animal 1 5.67 7.46 
Time 9 2.47 3.25 
Error 9 0.76 
Total 19 
Time (min.) 0 20 5 10 40 20 30 25 
MeanS 0.81 2.90 3.11 4.25 5.50 5.66 5.88 6.25 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 53. The effect of glucagon on plasma glucose levels in sheep 
Source of Variation d.f. M.S. 
Animals 1 152.90 4.16 
Time 9 4260.93 116.16 
Error 9 36.68 
Total 19 
Time (min.) 0 5 10 15 20 30 25 40 
Mean* 94.7 153.4 168.5 182.0 192.0 196.0 202.0 202.0 
^Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 54. The effect of glucagon on plasma urea nitrogen levels in 
sheep 
Source of Variation d.f. M.S. F 
Animals 1 122.51 41.52 
Time 9 4.90 1.66 
Error 9 2.95 
Total 19 
Time (min.) 25 0 15 5 40 30 20 10 
Mean* 18.0 18.1 18.2 19.0 19.0 21.0 21.2 21.8 
A^ny two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
Table 55. The effect of glucagon on plasma alpha amino nitrogen levels 
in sheep 
Source of Variation d.f. M.S. 
Animals 1 3.66 117.68 
Time 9 0.25 8.04 
Error 9 0.0311 
Total 19 
Time (min.) 40 30 25 20 0 10 15 5 
Mean* 2.42 2.58 2.75 2.95 3.16 3.28 3.30 3.52 
*Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
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Table 56. The effect of glucagon on plasma FFA levels in sheep 
Source of Variation d.f. M.S. F 
Animals 1 16704.20 2.38 
Time 9 111123.31 15.87 
Error 9 7000.42 
Total 19 
Time (min.) 40 30 25 20 15 0 10 5 
Mean* 475 506 610 746 844 938 1025 1187 
*Any two means not underscored by the same line are significantly 
different at 0.05 level of probability. 
